155 related articles for article (PubMed ID: 21154139)
1. Biological Therapeutics Research and Development--GTCbio's Fifth Annual Conference. October 20-22, 2010, San Francisco, CA, USA.
Garren H
IDrugs; 2010 Dec; 13(12):840-2. PubMed ID: 21154139
[TBL] [Abstract][Full Text] [Related]
2. PepTalk--CHI's Ninth Annual Meeting--Engineering Protein & Peptide Therapeutics: Peptides.
Craik D
IDrugs; 2010 Mar; 13(3):156-8. PubMed ID: 20191429
[TBL] [Abstract][Full Text] [Related]
3. The Immunotherapeutics and Vaccine Summit - CHI's fifth annual meeting - novel vaccines: adjuvants and delivery systems: part 2.
Jones SD
IDrugs; 2010 Oct; 13(10):692-4. PubMed ID: 20878589
[TBL] [Abstract][Full Text] [Related]
4. Natural peptides to drugs - fourth international congress.
Leone-Bay A
IDrugs; 2010 Jun; 13(6):369-71. PubMed ID: 20506056
[TBL] [Abstract][Full Text] [Related]
5. Modern Drug Discovery and Development--GTCbio's Third Annual Summit. Drug-Delivery Technology. 28-30 November 2007, San Francisco, CA, USA.
Lee RJ
IDrugs; 2008 Feb; 11(2):101-4. PubMed ID: 18240093
[No Abstract] [Full Text] [Related]
6. Gene Based Vaccines: Optimising Development and Delivery - A marcus evans Conference.
Garren H
IDrugs; 2010 Nov; 13(11):759-61. PubMed ID: 21046520
[TBL] [Abstract][Full Text] [Related]
7. Interscience Conference on Antimicrobial Agents and Chemotherapy--49th annual meeting. Part 2. 12-15 September 2009, San Francisco, CA, USA.
Turner B; Murch L
IDrugs; 2009 Nov; 12(11):670-2. PubMed ID: 19844847
[TBL] [Abstract][Full Text] [Related]
8. American Chemical Society-239th national meeting--Investigating new therapeutic candidates: part 2. 21-25 March 2010, San Francisco, CA, USA.
Kirkham K
IDrugs; 2010 May; 13(5):292-4. PubMed ID: 20432181
[TBL] [Abstract][Full Text] [Related]
9. American Chemical Society-239th national meeting--Investigating new therapeutic candidates: part 1. 21-25 March 2010, San Francisco, CA, USA.
Macauley D
IDrugs; 2010 May; 13(5):289-91. PubMed ID: 20432180
[TBL] [Abstract][Full Text] [Related]
10. Interscience Conference on Antimicrobial Agents and Chemotherapy--49th annual meeting. Part 1. 11-15 September 2009, San Francisco, CA, USA.
Turner B; Murch L
IDrugs; 2009 Nov; 12(11):667-9. PubMed ID: 19844846
[TBL] [Abstract][Full Text] [Related]
11. Vaccines in non-small cell lung cancer: rationale, combination strategies and update on clinical trials.
De Pas T; Giovannini M; Rescigno M; Catania C; Toffalorio F; Spitaleri G; Delmonte A; Barberis M; Spaggiari L; Solli P; Veronesi G; De Braud F
Crit Rev Oncol Hematol; 2012 Sep; 83(3):432-43. PubMed ID: 22366114
[TBL] [Abstract][Full Text] [Related]
12. The Immunotherapeutics and Vaccine Summit - CHI's fifth annual meeting - novel vaccines: adjuvants and delivery systems: part 1.
Jones SD
IDrugs; 2010 Oct; 13(10):689-91. PubMed ID: 20878588
[TBL] [Abstract][Full Text] [Related]
13. Vaccines for the treatment of non-small cell lung cancer: a renewed anticancer strategy.
Gridelli C; Rossi A; Maione P; Ferrara ML; Castaldo V; Sacco PC
Oncologist; 2009 Sep; 14(9):909-20. PubMed ID: 19726457
[TBL] [Abstract][Full Text] [Related]
14. Cytokines & inflammation--GTCbio's seventh annual conference. 29-30 January 2009, San Diego, CA, USA.
Fricker S
IDrugs; 2009 Apr; 12(4):214-6. PubMed ID: 19350461
[No Abstract] [Full Text] [Related]
15. IBC's 21st Annual Antibody Engineering and 8th Annual Antibody Therapeutics International Conferences and 2010 Annual Meeting of the Antibody Society. December 5-9, 2010, San Diego, CA USA.
Arnett SO; Teillaud JL; Wurch T; Reichert JM; Dunlop C; Huber M
MAbs; 2011; 3(2):133-52. PubMed ID: 21304271
[TBL] [Abstract][Full Text] [Related]
16. Medichem--BIT Life Sciences' First Annual International Conference.
Corson TW
IDrugs; 2010 Jul; 13(7):453-6. PubMed ID: 20582869
[TBL] [Abstract][Full Text] [Related]
17. Vaccine Manufacturing--Second Annual visiongain Conference.
McPherson C
IDrugs; 2010 Jul; 13(7):437-9. PubMed ID: 20582865
[TBL] [Abstract][Full Text] [Related]
18. Highly potent mRNA based cancer vaccines represent an attractive platform for combination therapies supporting an improved therapeutic effect.
Fotin-Mleczek M; Zanzinger K; Heidenreich R; Lorenz C; Thess A; Duchardt KM; Kallen KJ
J Gene Med; 2012 Jun; 14(6):428-39. PubMed ID: 22262664
[TBL] [Abstract][Full Text] [Related]
19. How nature morphs peptide scaffolds into antibiotics.
Nolan EM; Walsh CT
Chembiochem; 2009 Jan; 10(1):34-53. PubMed ID: 19058272
[TBL] [Abstract][Full Text] [Related]
20. The Immunotherapeutics & Vaccine Summit--CHI's fourth annual meeting. Preclinical/clinical development of immunotherapies and vaccines. 17-19 August 2009, Providence, RI, USA.
Butterfield LH
IDrugs; 2009 Oct; 12(10):633-5. PubMed ID: 19790013
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
